Buell Jennifer — SEC insider filings

SEC reporting owner CIK 1711184. 28 insider filings on record with FilingPulse; latest filed 2026-10-14.

Transaction summary — filings shown

Covers all 28 filings on record, filed 2020-12-21 to 2026-10-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MiNK Therapeutics, Inc. (INKT)Chief Executive Officer, Director11—1 leg · 6,938 sh · $73,26520
AGENUS INC (AGEN)See Remarks, Director16——18
Protagenic Therapeutics, Inc.\new (PTIX)Director1——1

Insider filings — Buell Jennifer

FiledFormIssuerReported transactionsSource
2026-10-144MiNK Therapeutics, Inc. (INKT)Option exercise (M): 23,191 · Sale (S): 6,938 @ $10.56 · Option exercise (M): 23,191 (derivative) @ $0EDGAR
2026-08-074AGENUS INC (AGEN)Grant/award (A): 200,000 (derivative) @ $0EDGAR
2026-04-284AGENUS INC (AGEN)Grant/award (A): 300,000 (derivative) @ $0 · Grant/award (A): 5,000 (derivative) @ $0EDGAR
2026-01-144/AMiNK Therapeutics, Inc. (INKT)Tax withholding (F): 10,024 @ $11.12EDGAR
2026-01-064MiNK Therapeutics, Inc. (INKT)Grant/award (A): 31,474 @ $11.12 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-10-034/AMiNK Therapeutics, Inc. (INKT)Tax withholding (F): 5,351 @ $15.36EDGAR
2025-09-114MiNK Therapeutics, Inc. (INKT)Grant/award (A): 18,229 @ $15.36 · Grant/award (A): 50,000 (derivative) @ $0EDGAR
2025-05-064AGENUS INC (AGEN)Grant/award (A): 581 @ $3.11EDGAR
2025-05-054AGENUS INC (AGEN)Grant/award (A): 869 @ $2.08EDGAR
2025-04-104AGENUS INC (AGEN)Grant/award (A): 1,159 @ $1.56EDGAR
2025-03-274AGENUS INC (AGEN)Grant/award (A): 1,123 @ $1.61EDGAR
2025-03-244AGENUS INC (AGEN)Grant/award (A): 409 @ $2.35EDGAR
2025-03-114AGENUS INC (AGEN)Grant/award (A): 545 @ $3.32EDGAR
2025-03-054AGENUS INC (AGEN)Grant/award (A): 626 @ $3.32EDGAR
2025-02-184AGENUS INC (AGEN)Grant/award (A): 516 @ $3.50EDGAR
2025-02-044AGENUS INC (AGEN)Tax withholding (F): 270 @ $3.57EDGAR
2025-01-284AGENUS INC (AGEN)Grant/award (A): 776 @ $3.57EDGAR
2024-11-184AGENUS INC (AGEN)Grant/award (A): 300,000 (derivative) @ $0EDGAR
2024-03-294Protagenic Therapeutics, Inc.\new (PTIX)Grant/award (A): 75,000 (derivative) @ $1.74EDGAR
2024-01-184MiNK Therapeutics, Inc. (INKT)Grant/award (A): 500,000 (derivative) @ $0 · Grant/award (A): 660,919 (derivative) @ $0EDGAR
2023-10-134MiNK Therapeutics, Inc. (INKT)Other (J): 695,750 · Grant/award (A): 695,750 (derivative) @ $0EDGAR
2023-10-034MiNK Therapeutics, Inc. (INKT)Tax withholding (F): 25,000 @ $1.15 · Tax withholding (F): 58,550 @ $1.04 · Tax withholding (F): 65,000 @ $0.94EDGAR
2023-09-294MiNK Therapeutics, Inc. (INKT)Option exercise (M): 695,750 · Option exercise (M): 695,750 (derivative) @ $0EDGAR
2023-01-114MiNK Therapeutics, Inc. (INKT)Grant/award (A): 171,990 @ $2.32 · Grant/award (A): 500,000 (derivative) @ $0EDGAR
2022-01-254MiNK Therapeutics, Inc. (INKT)Grant/award (A): 679,800 (derivative) @ $0EDGAR
2021-07-024AGENUS INC (AGEN)Grant/award (A): 10,597 @ $5.49 · Grant/award (A): 900,000 (derivative) @ $0EDGAR
2021-04-054AGENUS INC (AGEN)Grant/award (A): 80,838 @ $2.87EDGAR
2020-12-214AGENUS INC (AGEN)Grant/award (A): 900,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-12-17 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1711184 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs